Initial outcomes of mitomycin intravascular chemoembolization (MICE) for corneal neovascularization.

ABSTRACT:

Purpose

To report on the preliminary outcomes of mitomycin C (MMC) intravascular chemoembolization (MICE) for corneal neovascularization (NV).

Methods

This is a retrospective case series of three consecutive eyes that underwent MICE for progressive corneal NV with sight threatening lipid keratopathy. A 1.0 cc syringe was partially filled with MMC (0.4 mg/mL) and attached to a 33-gauge needle used to cannulate the vessels. The MMC (0.01-0.05 ml) was injected with enough retrograde hydrostatic force to fill efferent and afferent vessels. Follow-up ranged from 4 months to 1 year.

Results

Three eyes of three patients aged 59, 73 and 33 years were included. There were no intraoperative or postoperative complications associated with the MICE procedure. Patient 1 presented w

SUBMITTER: Mimouni M 

PROVIDER: S-EPMC8801928 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature